| 000 | 01193 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515035257.0 | ||
| 264 | 0 | _c20060816 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc061565 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOwen, Samantha | |
| 245 | 0 | 0 |
_aImatinib and altered bone and mineral metabolism. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cAug 2006 |
||
| 300 |
_a627; author reply 628-9 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBone and Bones _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypophosphatemia _xchemically induced |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aPhosphates _xblood |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPyrimidines _xadverse effects |
| 700 | 1 | _aHatfield, Alan | |
| 700 | 1 | _aLetvak, Laurie | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 355 _gno. 6 _gp. 627; author reply 628-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc061565 _zAvailable from publisher's website |
| 999 |
_c16487585 _d16487585 |
||